Претрага
Резултати
The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings
[2023]
Sretenović, Aleksandra M.; Mitrović, Marko; Vukosavljević, Nikola; Kecman, Natalija; Jovanović, Jelica V.; Bukumirić, Zoran M. Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients
[2017]
Marjanović, Irena M. Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia [2012]
Karan-Đurašević, TeodoraAssessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) [2018]
Djordjevic, Fedja RGeneric Imatinib in Chronic Myeloid Leukemia Treatment: Long-Term Follow-up
[2019]
Ćojbašić, Irena Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy
[2023]
Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S.
Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;
Assessment of Symptom Burden in Patients with Hematologic Malignancies using Edmonton Symptom Assessment System (ESAS) at the Time of Admission to the Institute for Oncology and Radiology of Serbia (IORS) as a Treatment Tailoring Concept [2019]
Dimitrijevic, JelenaPrognostic Significance of Cereblon Expression in Patients With Multiple Myeloma
[2016]
Bila, Jelena Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
[2015]
Bila, Jelena Early Evaluation and Therapy Adjustment in Advanced Stage Hodgkin Lymphoma-The Role of PET/CT
[2019]
Tucović, Aleksandra; Purić, Mila; Milanović, Nenad Филтери
По типу
- 20